These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19617223)

  • 1. Matrix metalloproteinase-2 and -9 exacerbate arterial stiffening and angiogenesis in diabetes and chronic kidney disease.
    Chung AW; Yang HH; Sigrist MK; Brin G; Chum E; Gourlay WA; Levin A
    Cardiovasc Res; 2009 Dec; 84(3):494-504. PubMed ID: 19617223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease.
    Chung AW; Yang HH; Kim JM; Sigrist MK; Chum E; Gourlay WA; Levin A
    Circulation; 2009 Sep; 120(9):792-801. PubMed ID: 19687355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of vascular endothelial growth factor paralleled with the increased angiostatin expression resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in human type 2 diabetic arterial vasculature.
    Chung AW; Hsiang YN; Matzke LA; McManus BM; van Breemen C; Okon EB
    Circ Res; 2006 Jul; 99(2):140-8. PubMed ID: 16778129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness.
    Yasmin ; McEniery CM; Wallace S; Dakham Z; Pulsalkar P; Maki-Petaja K; Ashby MJ; Cockcroft JR; Wilkinson IB
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):372. PubMed ID: 15556929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between circulating matrix metalloproteinase-2 and -9 and renal function in patients with chronic kidney disease.
    Chang HR; Yang SF; Li ML; Lin CC; Hsieh YS; Lian JD
    Clin Chim Acta; 2006 Apr; 366(1-2):243-8. PubMed ID: 16313894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.
    Toussaint ND; Lau KK; Strauss BJ; Polkinghorne KR; Kerr PG
    Nephrol Dial Transplant; 2008 Feb; 23(2):586-93. PubMed ID: 17933842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension.
    Tan J; Hua Q; Xing X; Wen J; Liu R; Yang Z
    Hypertens Res; 2007 Oct; 30(10):959-63. PubMed ID: 18049028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
    Rysz J; Banach M; Stolarek RA; Pasnik J; Cialkowska-Rysz A; Koktysz R; Piechota M; Baj Z
    J Nephrol; 2007; 20(4):444-52. PubMed ID: 17879211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased matrix metalloproteinase 2 activity in the human internal mammary artery is associated with ageing, hypertension, diabetes and kidney dysfunction.
    Chung AW; Booth AD; Rose C; Thompson CR; Levin A; van Breemen C
    J Vasc Res; 2008; 45(4):357-62. PubMed ID: 18332634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in the human matrix metalloproteinase-9 gene is associated with arterial stiffness in healthy individuals.
    Yasmin ; McEniery CM; O'Shaughnessy KM; Harnett P; Arshad A; Wallace S; Maki-Petaja K; McDonnell B; Ashby MJ; Brown J; Cockcroft JR; Wilkinson IB
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1799-805. PubMed ID: 16709939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EphA2 overexpression is associated with angiogenesis in ovarian cancer.
    Lin YG; Han LY; Kamat AA; Merritt WM; Landen CN; Deavers MT; Fletcher MS; Urbauer DL; Kinch MS; Sood AK
    Cancer; 2007 Jan; 109(2):332-40. PubMed ID: 17154180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction.
    Yasuda S; Miyazaki S; Kinoshita H; Nagaya N; Kanda M; Goto Y; Nonogi H
    Clin Sci (Lond); 2007 Jan; 112(1):43-9. PubMed ID: 16939410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter.
    Inoue K; Kamada M; Slaton JW; Fukata S; Yoshikawa C; Tamboli P; Dinney CP; Shuin T
    Clin Cancer Res; 2002 Jun; 8(6):1863-70. PubMed ID: 12060629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases.
    McLennan SV; Kelly DJ; Cox AJ; Cao Z; Lyons JG; Yue DK; Gilbert RE
    Diabetologia; 2002 Feb; 45(2):268-75. PubMed ID: 11935159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease?
    Peiskerová M; Kalousová M; Kratochvílová M; Dusilová-Sulková S; Uhrová J; Bandúr S; Malbohan IM; Zima T; Tesar V
    Kidney Blood Press Res; 2009; 32(4):276-83. PubMed ID: 19797911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging is associated with increased matrix metalloproteinase-2 activity in the human aorta.
    McNulty M; Spiers P; McGovern E; Feely J
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):504-9. PubMed ID: 15831360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of angiostatin in diabetic nephropathy.
    Zhang SX; Wang JJ; Lu K; Mott R; Longeras R; Ma JX
    J Am Soc Nephrol; 2006 Feb; 17(2):475-86. PubMed ID: 16394111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional arterial stiffness in patients with type 2 diabetes and chronic kidney disease.
    Kimoto E; Shoji T; Shinohara K; Hatsuda S; Mori K; Fukumoto S; Koyama H; Emoto M; Okuno Y; Nishizawa Y
    J Am Soc Nephrol; 2006 Aug; 17(8):2245-52. PubMed ID: 16837632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease.
    Wang MC; Tsai WC; Chen JY; Huang JJ
    Am J Kidney Dis; 2005 Mar; 45(3):494-501. PubMed ID: 15754271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
    Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.